Quick Answer
LeonaBio, Inc. reported Total Assets of $92.15 million for the year ending 2025.
- LeonaBio, Inc. showed an increase of +56.8% in Total Assets from 2024 to 2025.
- This data is from LeonaBio, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2020: $267.94 million | Q1 2021: $369.41 million | Q2 2021: $360.12 million | Q3 2021: $347.33 million | Q1 2022: $313.00 million | Q2 2022: $292.01 million | Q3 2022: $274.19 million | Q1 2023: $232.77 million | Q2 2023: $208.05 million | Q3 2023: $184.70 million | Q1 2024: $133.46 million | Q2 2024: $111.25 million | Q3 2024: $86.25 million | Q1 2025: $43.51 million | Q2 2025: $35.55 million | Q3 2025: $30.03 million.
- Over the full 7 years of available data (2019 to 2025), LeonaBio, Inc.'s Total Assets has grown by 4,109.7%.
- Historical annual values: Fiscal year 2025: $92.15 million | Fiscal year 2024: $58.78 million | Fiscal year 2023: $160.25 million | Fiscal year 2022: $258.15 million | Fiscal year 2021: $332.01 million | Fiscal year 2020: $279.56 million | Fiscal year 2019: $2.19 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: